Number of cases | 83 |
Mean age (Year) | 50 (min ± 12.8 8, max 71) |
| Male | 50 (60%) |
Gender | | |
| Female | 33 (40%) |
Karnofsky performance status ≥ 80 | 83 |
| radiotherapy after first surgery | 83/83 (100%) |
| chemotherapy after first surgery | 54/83 (65%) |
Adjuvant treatment | |
| radiotherapy after second surgery | 15/83 (18%) |
| chemotherapy after second surgery | 47/83 (56%) |
MGMT (tested methylated in a subset of patients treated with TMZ) | Primary GBM | 38/47 (81%) |
Recurrent GBM | 46/47 (98%) |
Time to recurrence (months) | 0.84–67.30 |
Survival after second surgery (months) | 0.03–25.75 |
Overall survival (months) | 0.84–70.48 |